4-1BB-Enhanced Expansion of CD8 ⁺ TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8 ⁺ T Cells.

Autor: Harao M; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MDACC, Houston, Texas., Forget MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Roszik J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Department of Genomic Medicine, The University of Texas MDACC, Houston, Texas., Gao H; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MDACC, Houston, Texas.; Department of Hematopathology, The University of Texas MDACC, Houston, Texas., Babiera GV; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MDACC, Houston, Texas.; Department of Breast Surgical Oncology, The University of Texas MDACC, Houston, Texas., Krishnamurthy S; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MDACC, Houston, Texas.; Department of Pathology, The University of Texas MDACC, Houston, Texas., Chacon JA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Li S; Department of Immunology, The University of Texas MDACC, Houston, Texas., Mittendorf EA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MDACC, Houston, Texas.; Department of Breast Surgical Oncology, The University of Texas MDACC, Houston, Texas., DeSnyder SM; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MDACC, Houston, Texas.; Department of Breast Surgical Oncology, The University of Texas MDACC, Houston, Texas., Rockwood KF; Department of Pathology, The University of Texas MDACC, Houston, Texas., Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Ueno NT; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MDACC, Houston, Texas.; Department of Breast Medical Oncology, The University of Texas MDACC, Houston, Texas., Radvanyi LG; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Vence L; Department of Immunology, The University of Texas MDACC, Houston, Texas., Haymaker C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas. chaymaker@mdanderson.org jreuben@mdanderson.org., Reuben JM; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MDACC, Houston, Texas. chaymaker@mdanderson.org jreuben@mdanderson.org.; Department of Hematopathology, The University of Texas MDACC, Houston, Texas.

Publikováno v: Cancer immunology research [Cancer Immunol Res] 2017 Jun; Vol. 5 (6), pp. 439-445. Date of Electronic Publication: 2017 May 04.

Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells.

Autor: Zeng ZZ; Department of Radiation Oncology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI 48109-0582, USA., Jia Y, Hahn NJ, Markwart SM, Rockwood KF, Livant DL

Publikováno v: Cancer research [Cancer Res] 2006 Aug 15; Vol. 66 (16), pp. 8091-9.